"Publication of the new AMA CPT code represents a significant milestone for Sensydia, and will help foster the adoption of our nninvasive, in-clinic hemodynamic assessment tool by establishing a ...
Sensydia Corp. reeled in $8 million in a financing round to advance its noninvasive Cardiac Performance System (CPS) platform, which uses heart sound analysis to enable earlier detection and better ...
A new tool may help patients better understand their long-term cardiovascular risk, researchers said. Based on the standard PREVENT risk calculator, researchers developed population-based age- and sex ...
LOS ANGELES--(BUSINESS WIRE)--Sensydia, a medical technology company pioneering non-invasive cardiac assessment, today announced that the first patient has been enrolled in its multi-center pivotal ...
Mayo Clinic is partnering with startup SandboxAQ to study a new medical device that uses quantum sensing technology and advanced AI algorithms for rapid diagnosis in cardiac care, such as potentially ...
Cardiovascular imaging, which continues to evolve alongside interventions and other technologies, made notable strides in the ...
For thousands of Americans each year, a bone marrow transplant has the potential to cure diseases such as leukemias, lymphomas and immune deficiency disorders. While lifesaving, bone marrow ...
In a recent study published in Nature Communications, researchers from the United States of America investigated the association between platelet hyperreactivity and the risk of cardiovascular events.
CMS released proposals to update cardiovascular disease risk assessment and risk management services. The organization proposed coding and payment for an atherosclerotic cardiovascular disease risk ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback